Cardiogramme Echographie Salle d'opération Salle d'opération
Logo   Accueil | Table des matières | Téléchargements | Liens |   Mentions légales   | Contact |Abréviations
Logo  

Bibliographie

Lectures conseillées

ABRAMS D, COMBES A, BRODIE D. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol 2014; 63:2769-78
BETTEX DA, CHASSOT PG, RUDIGER A. The weak heart: perioperative management. Cardiovasc Medicine 2016; in press
BORLAUG BA. The pathophysiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2014; 11:507-15
BRAUNWALD E. Heart failure. J Am Coll Cardiol Heart Fail 2013; 1:1-20
BRONICKI RA, BADEN HP. Pathophysiology of right ventricular failure in pulmonary hypertension. Pediatr Crit Care Med 2010; 11(Suppl):S15-S22
GUAZZI M, BORLAUG BA. Pulmonary hypertension due to left heart disease. Circulation 2012; 126:975-90
HADDAD F, DOYLE R, MURPHY DJ. HUNT SA. Right ventricular function in cardiovascular disease, Part II. Pathophysiology, clinical importance and management of right ventricular failure. Circulation 2008; 117:1717-31
McMURRAY JJV, ADAMOPOULOS S, ANKER SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 14:803-69
MEBAZAA A, PITSIS AA, RUDIGER A, et al. Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery. Critical Care 2010; 14:201
MILANOCA, SIMEONE AA. Mechanical circulatory support: devices, outcomes and complications. Heart Fail Rev 2013; 18:35-53
SHAH SJ. Pulmonary hypertension. JAMA 2012; 308:1366-74
SIMON MA. Assessment and treatment of right ventricular failure. Nat Rev Cardiol 2013; 10:204-18
SUBRAMANIAM K, BOISEN M, RAMESH V. Mechanical circulatory support for cardiogenic shock. Best Pract Res Clin Anaesthesiol 2012; 26:131-46
THUNBERG CA, GAITAN BD, GREWAL A, et al. Pulmonary hypertension in patients undergoing cardiac surgery: Pathophysiology, perioperative management, and outcomes. J Cardiothorac Vasc Anesth 2013; 27:551-72
YANCY CW, JESSUP M, BOZKURT B, et al. 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology Foundation / American Heart Association on Practice Guidelines. Circulation 2013; 128:e240-e327

 

Références


1 ABRAHAM WT, ADAMS KF, FONAROW GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005; 46:57-64
2 ABRAHAM WT, FISHER WG, SMITH AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-53
3 ABRAMS D, COMBES A, BRODIE D. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol 2014; 63:2769-78
4 AEBISCHER N, MALHOTTA R, CONNORS L, et al. Ventricular interdependence during Valsalva maneuver as seen by two-dimensional echocardiography: New insights about an old method. J Am Soc Echocardiogr 1995; 8:536-42
5 AIBA T, HESKETH GG, BARTH AS, et al. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronisation therapy. Circulation 2009; 119:1220-30
6 AISSAOUI N, LUYT CE, LEPRINCE P, et al. Predictors of successful extracorporeal membrane oxygenation weaning after assistance for refractory cardiogenic shock. Intensive Care Med 2011; 37:1738-45
7 ALLEN SJ, SIDEBOTHAM D. Postoperative care and complications after ventricular assist device implantation. Best Pract Res Clin Anaesthesiol 2012; 26:231-46
8 AMMAR KA, UMLAND MM, KRAMER C, et al. The ABCs of left ventricular assist device echocardiography: a systematic approach. Eur Heart J 2012; 13:885-99
9 ANDERSON JR, NAWARSKAS JJ. Pharmacotherapeutic management of pulmonary arterial hypertension. Cardiol Rev 2010; 18:148-62
10 ARCHER SL, MICHELAKIS ED. Phosphodiesterase type 5 inhibitors for pulmonary hypertension. N Engl J Med 2009; 361:1864-71
11 ARQUES S, ROUX E, LUCCIONI R. Current clinical applications of spectral tissue Doppler echocardiography (E/E’ ratio) as a noninvasive surrogate of left ventricular diastolic pressures in the diagnosis of heart failure with preserved left ventricular systolic function. Cardiovasc Ultrasound 2007; 5:16
12 ARULKUMARAN N, CORREDOR C, HAMILTON MA, et al. Cardiac complications associated with goal-directed therapy in high-risk surgical patients: a meta-analysis. Br J Anaesth 2014; 112:648-59
13 ASHES CM, YU M, MEINERI M, et al. Diastolic dysfunction, cardiopulmonary bypass, and atrial fibrillation after coronary artery bypass graft surgery. Brit J Anaesth 2014; 113:815-21
14 ATZ AM, WESSEL DL. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 1999; 91:307-10
15 AURIGEMMA GP, GAASH WH. Clinical practice: diastolic heart failure. N Engl J Med 2004; 351:1097-105
16 BADESCH DB, CHAMPION HC, GOMEZ SANCHEZ MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:S55-66
17 BADESCH DB, McLAUGHLIN VV, DELXROIX M, et al. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:56S-61S
18 BADIWALA MV, RAO V. Left ventricular device as destination therapy: are we there yet ? Curr Opin Cardiol 2009; 24:184-9
19 BARDIA A, MONTEALEGRE-GALLEGOS M, MAHMOOD F, et al. Left atrial size: An underappreciated perioperative cardiac risk factor. J Cardiothorac Vasc Anesth 2014; 28:1624-32
20 BARON JF, BERTRAND M, BARRE E, et al. Combined epidural and general anesthesia versus general anesthesia for abdominal aortic surgery. Anesthesiology 1991; 75:611-8
21 BARR FE, MACRAE D, Inhaled nitric oxide and related therapies. Pediatr Crit Care Med 2010; 11(Suppl): S30-S36
22 BARR FE, TIRONA RG, TAYLOR MB, et al. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension. J Thorac Cardiovasc Surg 2007; 134:319-26
23 BAUMWOL J, MACDONALD PS, KEOGH AM, et al. Right heart failure and “failure to thrive” after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transplant 2011; 30:888-95
24 BEDARD E, DIMOPOULOS K, GATZOULIS MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension ? Eur Heart J 2009; 30:256-65
25 BELLETTI A, CASTRO ML, SILVETTI S, et al. The effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trrials. Brit J Anaesth 2015; 115:656-75
26 BENEDETTO U, MELINA G, ROSCITANO A, et al. Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation ? A meta-analysis of 2479 patients. J Cardiovasc Med 2009 ; 10 :109-14
27 BENZA RL, MILLER DP, BARST RJ, et al. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from REVEAL. Chest 2012; 142:448-56
28 BENZA RL, MILLER DP, GOMBERG-MAITLAND M, et al. Predicting survival in pulmonary arterial hypertension. Insights from the Registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 2010; 122:164-72
29 BERMAN M, TSUI S, VUYLSTEKE A, et al. Life-threatening right ventricular failure in pulmonary hypertension : RVAD or ECMO ? J Heart Lung Transplant 2008 ; 27 :1188-9
30 BERNARD F, DENAULT A, BABIN D, et al. Diastolic dysfunction is predictive of difficult weaning from cardiopulmonary bypass. Anesth Analg 2001; 92:291-8
31 BERRY C, DOUGHTY RN, GRANGER C, et al. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012; 33:1750-7
32 BETTEX DA, CHASSOT PG, RUDIGER A. The weak heart: perioperative management. Cardiovasc Medicine 2016; in press
33 BIRKS EJ, GEORGE RS, HEDGER M, et al. Reversal of heart failure with a continuous-flow left ventricular assistance device and pharmacological therapy. Circulation 2011; 123:381-90
34 BLAISE G, LANGLEBEN D, HUBERT B. Pulmonary arterial hypertension. Anesthesiology 2003; 99:1415-32
35 BOGAARD HJ, ABE K, VONK NOORDEGRAAF A, et al. The right ventricle under pressure. Cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009; 135:794-804
36 BORLAUG BA. The pathophysiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2014; 11:507-15
37 BOVILL JG. Anesthesia for patients with impaired ventricular function. Semin Cardiothorac Vasc Anesth 2003; 7:49-54
38 BRAUN EB, PALIN CA, HOGUE CW. Vasopressin during spinal anesthesia in a patient with primary pulmnary hypertension treated with intravenous epoprostenol. Anesth Analg 2004; 99:36-7
39 BRAUNWALD E. Heart failure. J Am Coll Cardiol HF 2013; 1:1-20
40 BRAUNWALD E, COLUCCI WS. Clinical aspects of heart failure. In: BRAUNWALD E. Heart disease. A textbook of cardiovascular medicine. Philadelphia : W. B. Saunders Co, 1997, 445-70
41 BREITHARDT OA, STELLBRINK C. Current status of resynchronization therapy. Curr Opin Anesthesiol 2004; 17:75-83
42 BRISTOW MR. Antiadrenergic therapy of chronic heart failure. Surprises and new opportunities. Circulation 2003; 107:1100-2
43 BRISTOW MR, LINAS S, PORT JD. Drugs in the treatment of heart failure. In: ZIPES DP et al, Eds. Braunwald’s Heart Disease. A textbook of cardiovascular medicine. Philadelphia:Elsevier Saunders, 2005, 569-601
44 BRODDE OE. Pathophysiology of the beta-adrenoreceptor system in chronic heart failure. Eur Heart J 1991;12 (suppl F):54
45 BRODDE OE, DAUL A, MICHEL-REHNER L, et al. Agonist-induced desensitization of beta-adrenoreceptor function in humans. Circulation 1990; 81:914-21
46 BRODIE D, BACCHETTA M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med 2011; 365:1905-14
47 BRONICKI RA, BADEN HP. Pathophysiology of right ventricular failure in pulmonary hypertension. Pediatr Crit Care Med 2010; 11(Suppl):S15-S22
48 BRUCKNER BA, DIBARDINO DJ, NING Q, et al. High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII. J Heart Lung Transplant 2009; 28:785-90
49 BUCKBERG GD. Congestive heart failure: Treat the disease, not the symptom – Return to normalcy. J Thorac Cardiovasc Surg 2003; 125:S41-S49
50 BUNDTS W, VAN PELT N, GILLYNS H, et al. Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome. Heart 2001; 86:553-9
51 BURKHOFF D, SAYER G, DOSHI D, URIEL N. Hemodynamics of mechanical circulatory support. J Am Coll Cardiol 2015; 66:2663-74
52 CACCAMO M, ECKMAN P, JOHN R. Current state of ventricular assist devices. Curr Heart Fail Rep 2011; 8:91-8
53 CANNESSON M, FARHAT F, SCARLATA M, et al. The impact of atrio-biventricular pacing on hemodynamics and left ventricular dyssynchrony compared with atrio-right ventricular pacing alone in the postoperative period after cardiac surgery. J Cardiothorac Vasc Anesth 2009; 23:306-11
54 CAPDEVILLE M, INSLER S, SCALIA GM, et al. Anesthetic considerations for patient undergoing partial left ventriculectomy (Batista procedure). J Cardiothorac Vasc Anesth 1998; 12:101-7
55 CARP H, VEDHERA R, JAYARAM A, et al. Endogenous vasopressin and renin angiotensin systems support blood pressure after epidural block in humans. Anesthesiology 1994; 80:1000-7
56 CATENA E, MILAZZO F. Echocardiography and cardiac assist devices. Minerva Cardioangiol 2007; 55:247-65
57 CATENA E, TASCA G. Role of echocardiography in the perioperative managememnt of mechanical circulatory assistance. Best Pract Res Clin Anaesthesiol 2012; 26:199-216
58 CAVAROCCHI NC, PITCHER HT, YANG Q, et al. Weaning of extracorporeal membrane oxygenation using continuous hemodynamic transesophageal echocardiography. J Thorac Cardiovasc Surg 2013; 146:1474-9
59 CHAMPION HC, MICHELAKIS ED, HASSOUN PM. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit. Circulation 2009; 120:992-1007
60 CHASSOT PG, BETTEX DA. Anesthesia and adult congenital heart disease. J Cardiothorac Vasc Anesth 2006; 20: 414-37
61 CHASSOT PG, DELABAYS A, SPAHN DR. Preoperative evaluation of patients with or at risk of coronary artery disease undergoing non cardiac surgery. Brit J Anaesth 2002; 89:747-59
62 CHENG JM, DEN UIL CA, HOEKS SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: A meta-analysis. Eur Heart J 2009; 30:2102-8
63 CHENG R, HACHAMOVITCH R, KITTLSON M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1’866 adult patients. Ann Thorac Surg 2014; 97:610-6
64 CHRISTIANSEN S, KLOCKE A, AUTSCHBACH R. Past, present, and future of long term mechanical cardiac support in adults. J Card Surg 2008; 23:664-76
65 CHRISTOPHERSON R, BEATTIE C, FRANK SM, et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Anesthesiology 1993; 79:422-34
66 CHUMNANVEJ S, WOOD MJ, MacGILLIVRAY TE, et al. Perioperative echocardiographic examination for ventricular assist device implantation. Anesth Analg 2007; 105:583-601
67 CIOFOLO M, REIZ S. Circulatory effects of volatile anesthetic agents. Minerva Anaesthesiol 1999; 65:232-8
68 CLELAND JG, DAUBERT J, ERDMAN E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-49
69 COHN WE, TIMMS DL, FRAZIER OH. Total artificial hearts: past, present, and future. Nat Rev Cardiol 2015; 12:609-17
70 COLSON P, RYCKWAERT F, CORIAT P. Renin-angiotensin system antagonists and anesthesia. Anesth Analg 1999; 89:1143-55
71 COOK DJ, ROOKE GA. Priorities in perioperative geriatrics. Anesth Analg 2003; 96:1823-36
72 CORIAT P. Renin angiotensin aldosterone systems blockade and perioperative left ventricular function. Semin Cardiothorac Vasc Anesth 2003; 7:55-8
72a COUTURE P, DENAULT AY, SHI Y, et al. Effects of anesthetic induction in patients with diastolic dysfunction. Can J Anaesth 2009; 56:357-65
73 CROW S, CHEN D, MILANO C, et al. Acquired von Willebrand syndrome in continuous-flow assist device recipients. Ann Thorac Surg 2010; 90: 1263-9
74 CURTIS AB, WORLEY SJ, ADAMSON PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 2013; 368:1585-93
75 D’ALESSANDRO C, AUBERT S, GOLMARD JL, et al. Extra-corporeal membrane oxygenation temporary support for early graft failure after cardiac transplantation. Eur J Cardiothorac Surg 2010; 37:343-9
75a DANDEL M, POTAPOV E, KRABATSCH T, et al. Load dependency of right ventricular performance is a major factor to be considered in decision making before ventricular assist device implantation. Circulation 2013; 128(Suppl 1): S14-S23
76 DANG NC, TOPKARA VK, MERCANDO M, et al. Right heart failure after ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006; 25:1-6
77 DARWAZAH AK, BU SHAM’A RA, HUSSEIN E, et al. Myocardial revascularization in patients with low ejection fraction < 35%: effect of pump technique on early morbidity and mortality. J Card Surg 2006; 21:22-7
78 DEMEYRE R, DELCROIX M, DAENEN W. Anesthesia management for pulmonary endarterectomy. Curr Opin Anesthesiol 2005; 18:63-76
79 DENAULT AY, CHAPUT M, COUTURE P, et al. Dynamic right ventricular outflow tract obstruction in cardiac surgery. J Thorac Cardiovasc Surg 2006; 132:43-9
80 DENAULT AY, COUTURE P, BUITHIEU J, et al. Left and right ventricular diastolic dysfunction as predictors of difficult separation from cardio-pulmonary bypass. Can J Anesth 2006; 53:1020-9
81 DENAULT AY, HADDAD F, JACOBSOHN E, et al. Perioperative right ventricular dysfunction. Curr Opin Anaesthesiol 2013; 26:71-81
82 DENAULT AY, TARDIF JC, MAZER CD, et al. Difficult and complex separation from cardiopulmonary bypass in high-risk cardiac surgical patients: a multicenter study. J Cardiothorac Vasc Anesth 2012; 26:608-16
83 DE PERROT M, GRANTON JT, McRAE K, et al. Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience. J Thorac Cardiovasc Surg 2012; 143:910-8
84 DEVEREAUX PJ, YANG H, YUSUF S, et al, for the POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing nopn-cardiac surgery (POISE-trial): a randomised controlled trial. Lancet 2008; 371:1839-47
85 DIXON SR, HENRIQUES JPS, MAURI L, et al. A prospective feasibility trial investigating the use of Impella 2.5 system in patients undergoing high-risk percutanesous coronary intervention. J Am Coll Cardiol Interv 2009; 2:91-6
86 DOENST T. Surgical approaches to left ventricular reconstruction: a matter of perpective. Heart Fail Rev 2013; 18:15-25
87 DOUGHTY RN for the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012; 33:1750-7
88 DOUGHTY RN, RODGERS A, SHARPE N, et al. Effects of a beta-blocker therapy on mortality in patents with heart failure: A systematic overview of randomized controlled trials. Eur Heart J 1997; 18:560-5
89 DRAKOS SG, JANICKI L, HORNE BD, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010; 105:1030-5
89a DUNLAY SM, ROGER VL, WESTON SA, et al. Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circul Heart Fail 2012; 5:720-6
90 EBERT TJ, KANITZ DD, KAMPINE JP. Inhibition of synpathetic neural outflow during thiopental anesthesia in humans. Anesth Analg 1990; 71:319-26
91 EBERT TJ, MUZZI M. Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers: A comparison with isoflurane. Anesthesiology 1993; 79:444-53
92 EBERT TJ, MUZZI M, BERENS R, et al. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology 1992; 76:725-33
93 FANG JC, DE MARCO T, GIVERTZ MM, et al. World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult – a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2012; 31:913-33
94 FELDMAN T, CILINGIROGLU M. Percutaneous leaflet repair and annuloplasty for mitral regurgitation. J Am Coll Cardiol 2011; 57:529-37
95 FELLAHI JL, FISCHER MO, DACCACHE G, et al. Positive inotropic agents in myocardial ischemia-reperfusion injury. Anesthesiology 2013: 118:1460-5
96 FELLAHI JL, PARIENTI JJ, HANOUZ JL, et al. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome. Anesthesiology 2008; 108:979-87
97 FERINGA HHH, BAX JJ, SCHOUTEN O, et al. -blockers improve in-hospital and long-term survival in patients with severe left ventricular dysfunction undergoing major vascular surgery. Eur J Vasc Endovasc Surg 2006; 31:351-8
98 FEUSSNER M, MUKHERJEE C, GABARDE J, ENDER J. Anaesthesia for patients undergoing ventricular assist-device implantation. Best Pract Res Clin Anaesthesiol 2012; 26:167-77
99 FISCHER LG, VAN AH, BURKLE H. Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg 2003; 96:1603-16
100 FISHER MR, FORFIA PR, CHAMERA E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of plmonary hypertension. Am J Respir Crit Care Med 2009; 179:615-21
101 FLU WJ, VAN KUJIK JP, HOEKS SE, et al. Prognostic implications of asymptomatic left ventricular dysfunction in patients undergoing vascular surgery. Anesthesiology 2010; 112:1316-24
102 FOODY JM, FARREL MH, KRUMHOLZ HM. -blocker therapy in heart failure. Scientific review. JAMA 2002; 287:883-9
103 FORFIA PR, FISCHER MR, MATHAI SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006; 174:1034-41
104 FOWLER MB, ALDERMAN EL, OESTERLE SN, et al. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial bllood flow with dobutamine. Circulation 1984; 70:1103-111
105 FRANCIS GS, BARTOS JA, ADATYA S. Inotropes. J Am Coll Cardiol 2014; 63:2069-78
106 FRANK SM, FLEISHER LA, BRESLOW MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. [see comments.]. JAMA 1997; 277:1127-34
107 FRAZIER OH, GEMMATO C, MYERS TJ, et al. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J 2007; 34:275-81
108 FRIEDBERG MK, REDINGTON AN. Right versus left ventricular failure: differences, similarities, and interactions. Circulation 2014; 129:1033-44
109 FUJIWARA Y, MURRAY PA. Effects of isoflurane anesthesia on pulmonary vascular response to K+-ATP channel activation and circulatory hypotension in chronically instrumented dogs. Anesthesiology 1999; 90:799-81
110 FURNARY AP, JESSUP M, MOREIRA FLP. Multicenter trial of dynamic cardiomyoplasty for chronic heart failure. J Am Coll Cardiol 1996; 28:1175-9
111 GALIÉ N, BARBERA JA, FROST AE, et al. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med 2015; 373:834-44
112 GALIÉ N, CORRIS PA, FROST A, et al. Updated treatment algorithm of pulmonary artery hypertension. J Am Coll Cardiol 2013; 62:D60-72
113 GALIÉ N, HOEPER MM, HUMBERT M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30:2493-537
114 GALIÉ N, MANES A, NEGRO L, et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009; 30:394-403
115 GARRATI A, BRUSCHI G, COLOMBO T, et al. Noncardiac surgical procedures in patient supported with long-term implantable left ventricular assist device. Am J Surg 2009; 197:710-4
116 GATZOULIS MA, ROGERS P, LI W, et al. Safety and tolerability of bosentan in adults with Eisenmenger physiology. Int J Cardiol 2005; 98:147-51
117 GEKIERE JP, VALAT P, GOSSE P, KABBANI Y, JANVIER G. Fonction diastolique ventriculaire gauche: physiologie, physiopathologie, évaluation, moyens thérapeutiques, incidence en anesthésie. Ann Fr Anesth Réanim 1998; 17:319-39
118 GENOVESE EA, DEW MA, TEUTEBERG JJ, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg 2009; 88:1162-70
119 GERHARDT MA, BOOTH JV, CHESNUT LC, et al. Acute myocardial beta-adrenergic receptor dysfunction after cardiopulmonary bypass in patients with cardiac valve disease. Circulation 1998; 98:II275-II281
120 GHOFRANI HA, GALIÉ N, GRIMMINGER F, et al. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med 2013; 369:330-40
121 GILOTRA NA, RUSSEL SD. Patient selection for mechanical circulatory support. Heart Fail Rev 2013; 18:27-34
122 GIVERTZ MM, COLUCCI WS, BRAUNWALD E. Clinical aspects of heart failure; Pulmonary edema, high-output failure. In: ZIPES DP et al, Eds. Braunwald’s Heart Disease. A textbook of cardiovascular medicine. Philadelphia:Elsevier Saunders, 2005,539-68
123 GOERTZ AW, SEELIG W, HEINRICH H, et al. Influence of high thoracic epidural anesthesia on left ventricular contractility assessed using the end-systolic pressure-length relationship. Acta Anaesthesiol Scand 1993; 37:38-44
124 GONG B, LI Z, WONG PVY. Levosimendan treatment for heart failure: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth 2015; 29:1415-25
125 GÖRLINGER K, BERGMANN L, DIRKMANN D. Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 2012; 26:179-98
126 GRECO T, CALABRO MG, COVELLO RD, et al. A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br J Anaesth 2015; 114:746-56
127 GROBAN L, BUTTERWORTH J. Perioperative management of chronic heart failure. Anesth Analg 2006; 103:557-75
128 GROSSMAN AN, OPIE LH, BESHANSKY JR, et al. Glucose-insulin-potassium revived. Current status in acute coronary syndromes and the energy-depleted heart. Circulation 2013; 127:1040-8
129 GUAZZI M, BORLAUG BA. Pulmonary hypertension due to left heart disease. Circulation 2012; 126:975-90
130 GUAZZI M, VICENZI M, ARENA R, et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 2011; 124:164-74
130a GUIHAIRE J, HADDAD F, BOULATE D, et al. Non-invasive indices of right ventricular function are markers of ventriculo-arterial coupling rather than ventricular contractility: insights from a porcine model of chronic pressure overload. Eur Heart J Cardiovasc Imag 2013; 14:1140-9
131 HADDAD F, COUTURE P, TOUSIGNANT C, DENAULT AY. The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology and assessment. Anesth Analg 2009; 108:407-21
132 HADDAD F, DOYLE R, MURPHY DJ. HUNT SA. Right ventricular function in cardiovascular disease, Part II. Pathophysiology, clinical importance and management of right ventricular failure. Circulation 2008; 117:1717-31
132a HADDAD F, ELMI-SARABI M, FADEL E, et al. Pearls and pitfalls in managing right ventricular heart failure in cardiac surgery. Curr Opin Anaesthesiol 2016; 29:68-79
133 HADDAD F, FUH E, PETERSON T, et al. Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension. Circ Heart Fail 2011; 4:692-9
133a HADDAD F, GUIHAIRE J, SKHIRI M, et al. Septal curvature is marker of hemodynamic, anatomical, and electromechanical ventricular interdependence in patients with pulmonary arterial hypertension. Echocardiography 2014; 31:699-707
134 HADDAD F, HUNT SA, ROSENTHAL DN, et al. Right ventricular function in cardiovascular disease, Part I. Anatomy, physiology, aging and functional assessment of the right ventricle. Circulation 2008; 117:1436-48
135 HADDAD F, KUDELKO K, MERCIER O, et al. Pulmonary hypertension associated with left heart disease: Characteristics, emerging concepts, and treatment strategies. Progr Cardiovasc Dis 2011; 54:154-67
136 HAJ RM, CINCO E, MAZER CD. Treatment of pulmonary hypertension with selective pulmonary vasodilators. Curr Opin Anesthesiol 2006; 19:88-95
137 HALL JL, FERMIN DR, BIRKS EJ, et al. Clinical, molecular, and genomic changes in response to a left ventricular assist device. J Am Coll Cardiol 2011; 57:641-52
138 HAMMILL BG, CURTIS LH, BENNETT-GUERRERO E, et al. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology 2008; 108:599-67
139 HARRISON RW, HASSELBLAD V, MEHTA RH, et al. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2013; 27:1224-32
140 HERNANDEZ AF, SHEA AM, MILANO CA, et al. Long-term outcomes and costs of ventricular assist devices among medicare beneficiaries. JAMA 2008; 300:2398-406
141 HERNANDEZ AF, WHELLAN DJ, STROUD S, et al. Outcomes in heart failure patients after major noncardiac surgery. J Am Coll Cardiol 2004; 44:1446-53
142 HESS OM. Groupe de travail «insuffisance cardiaque» de la Société Suisse de Cardiologie. Recommandations pour le diagnostic et le traitement de l’insuffisance cardiaque chronique. Bull Médecins Suisses. 2003; 84:2097-107
143 HICKEY PR, HANSEN DD, STAFFORD M, MURPHY DJ. Pulmonary and systemic hemodynamic effects of nitrous oxide in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 1986; 65:374-8
144 HO JK, MAHAJAN A. Cardiac resynchronisation therapy for treatment of heart failure. Anesth Analg 2010; 111:1353-61
145 HOEFT A, BUHRE W. Anesthesia and the cardiovascular system. in: PRIEBE HJ, SKARVAN K. Cardiovascular physiology. London: BMJ Publishing Group, 1995, pp 272-306
146 HOEPER MM, BOGAARD HJ, CONDLIFFE R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62:D42-50
147 HSU PS, CHEN JL, HONG GJ, et al. Extracorporeal membrane oxygenation for refractory shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients. Eur J Cardiothorac Surg 2010; 37:328-33
148 HUMBERT M, SITBON O, SIMONNEAU G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351:1425-36
149 HUNTER KS, LEE PF, LANNING CJ, et al. Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension. Am Heart J 2008; 155:166-74
150 HUTFLESS R, KASANEGRA R, MADANI M, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004; 43:1873-9
151 IACCARINO G, et al. Reciprocal in vivo regulation of myocardial G-protein coupled receptor kinase expression by -adrenergic receptor stimulation and blockade. Circulation 1998; 98:1783-9
152 JAMIESON SW, KAPELANSKI DP, SAKAKIBARA N, et al. Pulmonary thromboendarterectomy: experience and lessons learned in 1’500 cases. Ann Thorac Surg 2003; 76:1457-64
153 JANDA S, SHAHIIDI N, GIN K, et al. Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart 2011; 97:612-22
154 JARDIN F, VIEILLARD-BARON A. Monitoring of right-sided heart function. Curr Opin Crit Care 2005; 11:271-9
155 JASON AC, CARTER C. Clinical relevance of the Bezold-Jarisch reflex. Anesthesiology 2003; 98:1250-60
156 JEON Y, RYU JH, LIM YJ, et al. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients. Eur J Cardoithorac Surg 2006; 29:952-6
157 JOHN R, MANTZ K, ECKMANN P, et al. Aortic valve pathophysiology during left ventricular assist device support. J Heart Lung Transplant 2010; 29:1321-9
158 JONES RH, VELAZQUEZ EJ, MICHLER RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009; 360:1705-17
159 JORDE UP, KUSHWAHA SS, TATOOLES AJ, et al. Results of the destination therapy with a continuous flow left ventricular assist device: a prospective study using INTERMACS registry. J Am Coll Cardiol 2014; 63:1751-7
160 JULIAN DG, CAMM AJ, FRANGIN G, et al. Randomized trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349:667-74
161 KANTROWITZ A, CARDONA RR, AU J, FREED PS. Intraaortic balloon pumping in congestive heart failure. In: HOSENPUD JD, GREENBERG BH. Congestive heart failure. Springr-Verlag, New York, 1994, p. 522-547
162 KASS DA, Ventricular resynchronization: pathophysiology and identification of responders. Rev Cardiovasc Med 2003; 4(suppl 2):S3-13
163 KEMP M, DONOVAN J, HIGHAM H, HOOPER J. Biochemical markers of myocardial injury. Br J Anaesth 2004; 93:63-73
164 KERBAUL F, RONDELET B, COLLART F, et al. Hypertension artérielle pulmonaire en anesthésie-réanimation. Ann Fr Anesth Réanim 2005; 24:528-40
165 KHAN H, METRA M, BLAIR JE, et al. Istaroxime, a first in class new chemical entity SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes ? Heart Fail Rev 2009; 14:277-87
166 KHAZIN V, KAUFMAN Y, ZABEEDA D, et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressure after cardiopulmonary bypass in children. J Cardiothor Vasc Anesth 2004; 18:156-9
167 KIKURA M, SATO S. The efficacy of preemptive milrinone or amrinone therapy in patients undergoing coronary artery bypass grafting. Anesth Analg 2002; 94:22-30
168 KIM NH, DELCROIX M, JENKINS DP, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62:D92-9
169 KIOWSKI W, SUTSCH G, DOSSEGGER L. Clinical benefit of angiotensin-converting enzyme inhibitors in chronic heart failure. J Cardiovasc Pharmacol 1996; 27:S19
170 KIRKLIN JK, NAFTEL DC, KORMOS RL, et al. Sixth INTERMACS annual report: a 10’000 patient database. J Heart Lung Transplant 2014; 33:555-64
171 KLOTZ S, SCHELD HH. Surgical approach to end-stage heart failure. Curr Opin Anesthesiol 2011; 24:86-91
172 KONDO U, KIM SO, NAKAYAMA M, et al. Pulmonary vascular effects of propofol at baseline, during elevated vasomotor tone and in response to sympathetic  and -adrenoreceptor activation. Anesthesiology 2001; 94:815-23
173 KRISTENSEN SD, KNUUTI J, SARASTE A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J 2014; 35:2383-431
174 KUCHER N, ROSSI E, DE ROSA M, et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mmHg or higher. Arch Intern Med 2005; 165:1777-81
175 KUMAR R, CHARONKO J, HUNDLEY WG, et al. Assessment of left ventricular diastolic function using 4-dimensional phase-contrast cardiac magnetic resonance. J Comput Assist Tomogr 2011; 35:108-12
176 KWAK YL, LEE CS, PARK YH, et al. The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension. Anaesthesia 2002; 57:9-14
177 LAFFEY JG, BOYLAN JF, CHENG DC. The systemic inflammatory response to cardiac surgery. Anesthesiology 2002; 97:215-52
178 LAHM T, McCASLIN CA, WOZNIAK TC, et al. Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol 2010; 56:1435-46
179 LAM CSP, ROGER VL, RODEHEFFER RJ, et al. Pulmonary hypertension in heart failure with preserved ejection fraction. A community-based study. J Am Coll Cardiol 2009; 53:1119-26
180 LAMARCHE Y, MALO O, THORIN E, et al. Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 130:83-92
181 LAMPERT BC, TEUTEBERG JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transpl 2015; 34:1123-30
182 LANDONI G, BIONDI-ZOCCAI GGL, GRECO M, et al. Effects of levosimendan on mortality and hospitalization: a meta-analysis of randomized controlled trials. Crit Care Med 2012; 40:634-46
183 LANG IM, MADANI M. Update on chronic thromboembolic pulmonary hypertension. Circulation 2014; 130:508-18
184 LANKHAAR JW, WESTERHOF N, FAES TJC, et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 2006; 291:H1731-H1737
185 LANKHAAR JW, WESTERHOF N, FAES TJC, et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J 2008; 29:1688-95
186 LAU EMT, MANES A, CELERMAJER DS, GALIE N. Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. Eur Heart J 2011; 32:2489-98
187 Lee th, marcantonio er, mangione cm, ET AL. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-9
188 LEHMANN A, KIESSLING AH, ISGRO F, et al. Levosimendan in patients with acute myocardial ischemia undergoing emergency surgical revascularisation. Eur J Anaethesiol 2008; 25:224-9
189 LENNON PF, MURRAY PA. Attenuated hypoxic pulmonary vasoconstriction during isoflurane anesthesia is abolished by cyclooxygenase inhibition in chronically instrumented dogs. Anesthesiology 1996; 84:404-14
190 LEPORE JJ, MAROO A, BIGATELLO LM, et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest 2005; 127:1647-53
191 LEYVA F, NISAM S, AURICCHIO A. 20 years of cardiac resynchronization therapy. J Am Coll Cardiol 2014; 64:1047-58
192 LICKER M, SCHWEIZER A. Vasopressin and postcardiopulmonary bypass refractory hypotension. Anesth Analg 1999; 88:695
193 LIETZ K, LONG JW, KFOURY AG, et al. Outcome of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007; 116:497-505
194 LIM GB. Prognostic relevance of pulmonary hypertension in valvular disease. Nat Rev Cardiol 2015; 12:194
195 LONDON MJ, HUR K, SCHWARTZ GG, et al. Association of perioperative -blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 2013; 309:1704-13
196 LONG JW, KFOURY AG, SLAUGHTER MS, et al. Long term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 2005; 11:133-8
197 LOOR G, GONZALES-STAWINSKI G. Pulsatile vs continuous flow in ventricular assist device therapy. Best Pract Res Clin Anaesthesiol 2012; 26:105-15
198 LOUBSER PG, COHEN E, NEUSTEIN S. Pulmonary reperfusion edema associated with pulmonary thromboendarterectomy. J Cardiothorac Vasc Anesth 1998; 12:353-7
199 LOWES BD, TSEVTKOVA T, EICHHORN EJ, et al. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol 2001; 81:141-9
200 LUND LH, EDWARDS LB, KUCHERYAVAYA AY, et al. The Registry of the International Society for Heart and Lung transplantation: Thirty-second official Adult Heart Transplantation Report-2015. Focus theme: early graft failure. J Heart Lung Transplant 2015; 34:1244-54
201 LURATI BUSE GAL, BOLLIGER D, SEEBERGER E, et al. Troponin T and B-Type Natriuretic Peptide after on-pump cardiac surgery. Circulation 2014; 130:948-57
202 MACHUCA TN, DE PERROT M. Mechanical support for the failing right ventricle in patients with precapillary pulmonary hypertension. Circulation 2015; 132:526-36
203 MADANI MM, AUGER WR, PRETORIUS V, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2’700 patients. Ann Thorac Surg 2012; 94:97-103
204 MAGNER JJ, ROYSTON D. Heart Failure. Br J Anaesth 2004; 93:74-85
205 MAHAPATRA S, NISHIMURA RA, SORAJJA P, et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 2006; 47:799-803
206 MAHARAJ R, METAXA V. Levosimendan and mortality after coronary artery revascularisation: a meta-analysis of randomised controlled trials. Critical Care 2011; 15:R140
207 MAILE MD, ENGOREN MC, TREMPER KK, et al. Worsening preoperative heart failure is associated with mortality and noncardiac complications, but not myocardial infarction after noncardiac surgery: A retrospective cohort study. Anesth Analg 2014; 119:522-32
208 MANCINI D, COLOMBO PC. Left ventricular assist devices. A rapidly evolving alternative to transplant. J Am Coll Cardiol 2015; 65:2542-55
209 MANECKE GR, KOTZUR A, ATKINS G et al. Massive pulmonary hemorrhage after pulmonary thromboendarterectomy. Anesth Analg 2004; 99:672-5
210 MARES P, GILBERT BG, TSCHERNKO EM, et al. Pulmonary artery thromboendarterectomy: a comparison of two different postoperative treatment strategies. Anesth Analg 2000; 90:267-73
211 MATTHEWS JC, KOELLING TM, PAGANI FD, et al. The right ventricular failure risk score. J Am Coll Cardiol 2008; 51:2163-72
212 MAYBAUM S, MANCINI D, XYDAS S, et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007; 115:2497-505
213 MAYTAL R, SKUBAS NJ, SHERNAN SK, MAHMOOD F. Perioperative assessment of diastolic dysfunction. Anesth Analg 2011; 113:449-72
214 McLAUGHLIN W, ARCHER SL, BADESCH DB et al. ACC/AHA 2009 expert consensus document on pulmonary hypertension : A report of the American College of Cardiology Foundation Task Force on expert consensus documents and the American Heart Association. Circulation 2009; 119:2250-94
215 McLAUGHLIN W, GAINE SP, HOWARD LS, et al. Treatment goals of pulmonary hypertension. J Am Coll Cardiol 2013; 62:D73-81
216 McLAUGHLIN W, SHAH SJ, SOUZA R, HUMBERT M. Management of pulmonary arterial hypertension. J Am Coll Cardiol 2015; 65:1976-97
217 McMURRAY JJV, ADAMOPOULOS S, ANKER SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 14:803-69
218 McMURRAY JJ, PACKER M, DESAI AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014; 371:993-1004
219 MEBAZAA A, NIEMINEN MS, PACKER M, et al. Levosimendan versus dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial. JAMA 2007; 297:1883-91
220 MEBAZAA A, PARISSIS J, PORCHER R, et al. Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Intensive Care Med 2011; 37:290-301
221 MEHRA MR, KOBASHIGAWA J, STARLING R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates – 2006. J Heart Lung Transplant 2006; 25:1024-42
222 MELENOVSKY V, HWANG SJ, LIN G, et al. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 2014; 35:3452-62
223 MEMTSOUDIS SG, MA Y, CHIU YL, et al. Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement. Anesth Analg 2010; 111:1110-6
224 MENTZ RJ, KELLY JP, VON LUEDER TG, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 2014; 64:2281-93
225 METRA M, NODARI S, D’ALOIA A, et al. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol 2002; 40:1248-58
226 METS B. Anesthesia for left-ventricular assist device placement. J Cardiothorac Vasc Anesth 2000; 14:316-26
227 MICHARD F. Changes in arterial pressure during mechanical ventilation. Anesthesiology 2005; 103:419-28
228 MICHELAKIS E, TYMCHAK W, LIEN D, et al. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide. Circulation 2002; 105:2398-403
229 MILANOCA, SIMEONE AA. Mechanical circulatory support: devices, outcomes and complications. Heart Fail Rev 2013; 18:35-53
230 MILLER LW, GUGLIN M, ROGERS J. Cost of ventricular assist devices. Can we afford the progress ? Circulation 2012; 127:743-8
231 MISHRA V, SVENNEVIG JL, BUGGE JF, et al. Cost of extracorporeal membrane oxygenation: evidence from the Rikshospitalet University Hospital, Oslo, Norway. Eur J Cardiothorac Surg 2010; 37:339-42
232 MITTER N, SHEINBERG R. Update on ventricular assist devices. Curr Opin Anaesthesiol 2009; 23:57-66
233 MOE GW, HOWLETT J, JANUZZI JL, et al. N-terminal Pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure. Circulation 2007; 115:3103-10
234 MOHACSI P, STALDER M, MARTINELLI M, et al. Transplantation cardiaque et assistance circulatoire mécanique. Situation actuelle et perspectives. 2ème partie. Forum Med Suisse 2011; 11:98-102
235 MÖLLHOF T, THEILMEIER G, VAN AKEN H. Regional anaesthesia in patients at coronary risk for noncardiac and cardiac surgery. Curr Opin Anaesthesiol 2001; 14:17-25
236 MOREIRA LFP, STOLF NAG, BOCCHI EA, et al. Partial left ventriculectomy with mitral valve preservation in the treatment of patients with dialted cardiomyopathy. J Thorac Cardiovasc Surg 1998; 115:800-5
237 MORELLI A, TEBOUL JL, MAGGIORE SM, et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome. A pilot study. Crit Care Med 2006; 34:2287-93
238 MULIERI LA, LEAVITT BJ, MARTIN BJ, et al. Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin. Circulation 1993; 88:2700-4
239 MUNT B, JUE J, GIN K, et al . Diastolic filling in human severe sepsis: an echocardiographic study. Crit Care Med 1998; 26:1829-33
240 NAIDU SS. Novel percutaneous cardiac assist devices. The science of and incications for hemodynamic support. Circulation 2011; 123:533-43
241 NAKAYAMA M, KONDO U, MURRAY PA. Pulmonary vasodilator response to adenosine triphosphate-sensitive potassium channel activation is attenuated during desflurane but preserved during sevoflurane anesthesia compared with the conscious state. Anesthesiology 1998; 88:1023-35
242 NG J, FINNEY S, SHULMAN R, et al. Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil ? Br J Anaesth 2005; 94:774-7
243 NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-97
244 NICOARA A, SWAMINATHAN M. Diastolic dysfunction, diagnostic and perioperative management in cardiac surgery. Curr Opin Anaesthesiol 2015; 28:60-6
244a NICOARA A, JONES-HAYWOOD M. Diastolic heart failure: diagnosis and therapy. Curr Opin Anaesthesiol 2016; 29:61-7
245 NICOLOSI AC, PAGEL PS. Perioperative considerations in the patient with a left ventricular assist device. Anesthesiology 2003; 98:565-70
246 NIELSEN DV, HANSEN KM, JOHNSEN SP, et al. Health outcomes with and without use of inotropic therapy in cardiac surgery. Anesthesiology 2014; 120:1098-108
247 NIES AS. Clinical pharmacokinetics in congestive heart failure. In: HOSENPUD JD, GREENBERG BH. Congestive heart failure. Springer-Verlag, New-York, 1994, p 323-340
248 NOHRIA A, LEWIS E, STEVENSON LW. Medical management of advanced heart failure. JAMA 2002; 287:628-40
249 NORRIS EJ, BEATTIE C, PERLER BA, et al. Double-masked randomized trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery. Anesthesiology 2001; 95:1054-67
250 NOVITZKY D, FONTANET H, SNYDER M, et al. Impact of tri-iodo-thyronine on the survival of high-risk patients undergoing heart surgery. Cardiology 1996; 87:509-15
251 O’CONNOR CM, STARLING RC, HERNANDEZ AF, et al. Effect of Nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365:32-43
252 OGAWA K, TANAKA S, MURRAY PA. Inhibitory effects of etomidate and ketamine on endothelium-dependent relaxation in canine pulmonary artery. Anesthesiology 2001; 94:668-77
253 O’HARA DA, DUFF A, BERLIN JA, et al. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000; 92:947-57
254 OPIE LH. Heart physiology. From cell to circulation. 4th edition. Philadelphia: Lippincott Williams & Wilkins 2004, 485-524
255 OPOTOWSKY AR. Clinical evaluation and management of pulmonary hypertension in the adult with congenital heart disease. Circulation 2015; 131:200-10
256 PACKER M, COLUCCI W, FISHER L, et al. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. J Am Coll Cardiol Heart Fail 2013; 1:103-11
257 PAGEL PS. Levosimendan in cardiac surgery: A unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application ? Anesth Analg 2007; 104:759-61
258 PAGEL PS, GROSSMANN W, HAERING M, WARLTIER DC. Left ventricular diastolic function in the normal and diseaesed heart. Anesthesiology 1993; 79:836-54 (Part I) et 79:1104-20 (Part II)
259 PALEVSKY HI, SCHLOO BL, PIETRA CC, et al. Primary pulmonary hypertension: Vascular structure, morphometry, and responsiveness to vasodilator agents. Circulation 1989; 80:1207-21
260 PAPP Z, EDES I, FRUHWALD S, et al. Levosimendan: molecular mechanisms and clinical implications. Consensus of experts on the mechanism of action of levosimendan. Intern J Cardiol 2012; 159:82-7
261 PARK SJ, KIM SP, KIM JB, et al. Blood lactate level during extracorporeal life support as a surrogate marker for survival. J Cardiothorac Vasc Surg 2014; 148:714-20
262 PARK SJ, MILANO CA, TATOOLES AJ, et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 2012; 5:241-8
263 PARK WY, THOMPSON JS, LEE KK. Effect of epidural anesthesia and analgesia on perioperative outcome: A randomized, controlled Veteran Affairs cooperative study. Ann Surg 2001; 234:560-9
264 PASCALE F, JEANRENAUD X. Thérapie de resynchronisation: échocardiographie et critères de selection. Rev Med Suisse 2007; 3:1383-90
265 PATEL BM, CHITTOK DR, RUSSEL JA, WALLEY KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-82
266 PATRONITI N, SANGALLI F, AVALLI L. Post-acrdiac arrest extracorporeal life support. Best Pract Res Clin Anaesthesiol 2015; 29:497-508
267 PAULUS WJ, TSCHÖPE C. A novel paradigm for heart failure with preserved ejection fraction. J Am Coll Cardiol 2013; 62:263-71
268 PAULUS WJ, TSCHÖPE C, SANDERSON JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28:2539-50
269 PENGO V, LENSING AWA, PRINS M, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350:2257-64
270 PERERA D, STABLES R, CLAYTON D, et al. Long terme mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation 2013; 127:207-12
271 PINSKY MR, MARGUER J, MARTIN D, et al. Ventriculrar assistance by cardiac cycle specific increase in intrathoracic pressure. Chest 1987; 91:709-15
272 PIRES LA. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy. Curr Opin Anesthesiol 2006; 19:69-74
273 PITT B, ZANNAD F, REMME WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341:709-17
274 PLATTS DG, SEDGWICK JF, BURSTOW DJ, et al. The role of echocardiography in the management of patients supported by extracorporeal membrane oxygenation. J Am Soc Echocardiogr 2012; 25:131-41
275 POST SR, HAMMOND HK, INSEL PA. Beta-adrenergic receptors and receptor signaling in heart failure. Ann Rev Pharmacol Toxicol 1999; 39:343-60
276 PULIDO JN, PARK SJ, RIHAL CS. Percutaneous left ventricular assist devices: Clinical uses, future applications, and anesthetic considerations. J Cardiothorac Vasc Anesth 2010; 24:478-86
277 RAJA SG, DANTON MD, MacARTHUR KJ. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence. J Cardiothorac Vasc Anesth 2006; 20:722-35
278 RAMAKRISHNA G, SPRUNG J, RAVI BS, et al. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005; 45:1691-9
279 REGITZ-ZAGROSEK V, LUNDQVIST CB, BORGHI C, et al. ESC Guidelines on the management of cardiovascular disease during pregnancy. Eur Heart J 2011; 32:3147-97
280 REX S, MISSANT C, SEGERS P, WOUTERS P. Thoracic epidural anesthesia impairs the hemodynamic response to acute pulmonary hypertension by deteriorating right ventricular-pulmonary arterial coupling. Crit Care Med 2007; 35:222-9
281 RICH JD, SHAH SJ, SWAMY RS, et al. Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension. Chest 2011; 139:988-93
282 RICH S, KAUFMANN E, LEVY PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327:76-81
283 RICH S, McLAUGHLIN VV. Pulmonary hypertension. In: ZIPES DP, et al, eds. Braunwald’s heart disease. A textbook of cardiovascular medicine. Philadelphia: Elsevier Saunders, 2005, 1807-42
284 RICH S, ROOS CM, ANDERSON SM, et al. Direct effects of intravenous anesthetics on pulmonary vascular resistance in the isolated rat lung. Anesth Analg 1994; 78:961-6
285 RICHALET JP, GRATADOUR P, ROBACH P, et al. Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Resp Crit Care Med 2004; 171:275-81
286 RIHAL CS, NAIDU SS, GIVERTZ MM, et al. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Stete,ent on the use of percutaneous mechanical circulatory support devices in cardiovascular care. J Am Coll Cardiol 2015; 65:e7-e26
287 RIOU B, ADNET F, BAUD F, et al. Recommandations sur les indications de l’assistance circulatoire dans le traitement des arrêts cardiaques réfractaires. Ann Fr Anesth Réanim 2009; 28:182-6
288 ROBITAILLE A, DENAULT AY, COUTURE P, et al. Importance of relative pulmonary hypertension in cardiac surgery: the mean systemic-to-pulmonary artery pressure ratio. J Cardiothorac Vasc Anesth 2006; 20:331-9
289 RODSETH RN, BICCARD BM, CHU R, et al. Postoperative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery. Systematic review and individual patient meta-analysis. Anesthesiology 2013; 119:270-83
290 ROGERS JG, AARONSON KD, BOYLE AJ, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010; 55:1826-34
291 ROSE EA, GELIJNS AC, MOSKOWITZ AJ, et al. REMATCH study group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345:1435-43
292 RUBIN LJ, BADESCH DB, BARST RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346:896-903
293 SACKNER-BERNSTEIN JD, SKOPICKI HA, AARONSON KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005; 111:1487-91
294 SAEED D, KIDAMBI T, SHALLI S, et al. Tricuspid valve repair with left ventricular assist device implantation: is it warranted ? J Heart Lung Transplant 2011; 30:530-5
295 SALZBERGS P, FILSOUFI F, ANYANWU A, et al. High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg 2005; 80:502-6
296 SARKAR S, GUHABISWAS R, RUPERT E. Echocardiographic evaluation and comparison of the effects of isoflurane, sevoflurane and desflurane on left ventricular indices in patients with diastolic dysfunction. Ann Cardiac Anaesth 2010; 13:180-7
297 SARKAR M, LAUSSEN PC, ZURAKOWSKI D, et al. Hemodynamic responses to etomidate on induction of anesthesia in pediatric patients. Anesth Analg 2005; 101:645-50
298 SCHROEDER RA, WOOD GL, PLOTKIN JS, et al. Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure. Anesth Analg 2000; 91:291-5
299 SCHWARTZ AJ, HENSLEY FA. Case conference: A 62-year-old man is scheduled for a new cardiac surgical procedure: dynamic cardiomyoplasty. J Cardiothor Vasc Anesth 1993; 6:476-87
300 SELKER HP, BESHANSKY JR, SHEEHAN PR, et al. Out-of-hospital administration of intravenous glucose-isulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA 2012; 307:1925-33
300a SENNI M, PAULUS WJ, GAVAZZI A, et al. New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes. Eur Heart J 2014; 35:2797-811
301 SHAHIN J, DE VARENNES B, TSE CW, et al. The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Critical Care 2011; 15:R162
302 SHAN K, BICK RJ, POINDEXTER DJ, et al. Altered adrenergic recepor density in myocardial hibernation in humans: a possible mechanism of depressed myocardial function. Circulation 2000; 102:2599-606
303 SHENOY V, ANTON JM, COLLARD C, YOUNGBLOOD SC. Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Anesthesiology 2014; 120:1255-61
304 SHIBA N, CHAN MC, VALENTINE HA, et al. Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. J Heart Lung Transplant 2003; 22:1098-106
305 SHIN TG, JO JH, SIM MS, et al. Two-year survival and neurological outcome of in-hospital cardiac arrest patients rescued by extracorporeal cardiopulmonary resuscitation. Int J Cardiol 2013; 168:3424-30
306 SIDEBOTHAM D, ALLEN SJ, McGEORGE A, et al. Venovenous extracorporeal membrane oxygenation in adults: Practical aspects of circuits, cannulae, and procedures. J Cardiothorac Vasc Anesth 2012; 26:893-909
307 SIDEBOTHAM D, McGEORGE A, McGUINESS S, et al. Extracorporel membrane oxygenation for treating severe cardiac and respiratory disease in adults: Part 1 – Technical considerations. J Cardiothorac Vasc Anesth 2009; 23:886-92
308 SIDEBOTHAM D, McGEORGE A, McGUINESS S, et al. Extracorporel membrane oxygenation for treating severe cardiac and respiratory disease in adults: Part 2 – Overview of ECMO. J Cardiothorac Vasc Anesth 2010; 24:164-72
309 SIMON MA. Assessment and treatment of right ventricular failure. Nat Rev Cardiol 2013; 10:204-18
310 SIMONEAU G, GATZOULIS MA, ADAIA I,, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62:D34-41
311 SIMPSON JI. Hemodynamic effects of the inhalational anesthetic agents. In: SIMPSON JI, Editor. Anesthesia and the patient with coexisting heart disease. Little, Brown and Co, Boston 1993, p13-26
312 SKIDMORE KL, RUSSEL IA. Brain natriuretic peptide: A diagnostic and treatment hormone for perioperative congestive heart failure. J Cardiothorac Vasc Anesth 2004; 18:780-7
313 SLAUGHTER MS, ROGERS JG, MILANO CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361:2241-51
314 SLININGER KA, HADDADIN AS, MANGI AA. Perioperative management of patients with left ventricular assist devices undergoing noncardiac surgery. J Cardiothorac Vasc Anesth 2013; 27:752-9
315 SMILEY RM, VUILLEMOZ Y. Cardiac surgery causes desensitization of the -adrenergic system of immune lymphocytes. Anesth Analg 1992; 74:212-8
316 STEIN E, RAMAKRISHNA H, AUGOUSTIDES JGT. Recent advances in chronic thromboembolic pulmonary hypertension. J Cardiothorac Vasc Anesth 2011; 25:744-8
317 STENSETH R, BJELLA L, BERG EM. Effect of thoracic epidural analgesia on coronary hemodynamics and myocardial metabolim in coronary artery bypass surgery. J Cardiothor Vasc Anesth 1995; 9:503-9
318 STEVENS GR, GARCIA-ALVAREZ A, SAHNI S, et al. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. JACC Cardiovasc Inaging 2012; 5: 378-87
319 STEVENSON LW, PAGANI FD, YOUNG JB, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009; 28:535-41
320 STONE GW, OHMAN EM, MILLER MF, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction. J Am Coll Cardiol 2003; 41:1940-6
321 STRUMPHER J, JACONSOHN E. Pulmonary hypertension and right ventricular dysfunction: physiology and perioperative management. J Cardiothorac Vasc Anesth 2011; 25: 687-704
322 SUBRAMANIAM K, BOISEN M, RAMESH V. Mechanical circulatory support for cardiogenic shock. Best Pract Res Clin Anaesthesiol 2012; 26:131-46
323 SUBRAMANIAM K, YARED JP. Management of pulmonary hypertension in the operating room. Semin Cardiothor Vasc Anesth 2007; 11:119-36
324 SWAMINATHAN M, NICOARA A, PHILLIPS-BUTE BG, et al. Utility of a simple algorithm to grade diastolic dysfunction and predict outcome after coronary artery bypass graft surgery. Ann Thorac Surg 2011; 91:1844-51
325 TACON CL, McCAFFREY J, DELANEY A. Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials. Intens Care Med 2012; 38:359-67
326 TANIGUCHI M, KASABA T, TAKASAKI M. Epidural anesthesia enhances sympathetic nerve activity in the unanesthetized segments in cats. Anesth Analg 1997; 84:391-7
327 TAYLOR DO, STEHLIK J, EDWARDS LB, et al. Registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2009; 28:1007-22
328 TAYLOR MB, LAUSSEN PC. Fundamentals of management of acute postoperative pulmonary hypertension. Pediatr Crit Care Med 2010; 11(Suppl): S27-S29
329 TERRACCIANO CM, MILLER LW, YACOUB MH. Contemporary use of ventricular assist devices. Annu Rev Med 2010; 61:255-70
330 THENAPPAN T, SHAH SJ, RICH S, et al. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 2010; 35:1079-87
331 THIELE H, ZEYMER U, NEUMANN FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367:1287-96
332 THIELE H, ZEYMER U, NEUMANN FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 months results of a randomised, open-label trial. Lancet 2013; 382:1638-45
333 THISTLETHWAITE PA, MO M, MADANI MM, et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2002; 124:1203-11
334 THUNBERG CA, GAITAN BD, ARABIA FA, et al. Ventricular assist devices today and tomorrow. J Cardiothorac Vasc Anesth 2010: 24:656-80
335 THUNBERG CA, GAITAN BD, GREWAL A, et al. Pulmonary hypertension in patients undergoing cardiac surgery: Pathophysiology, perioperative management, and outcomes. J Cardiothorac Vasc Anesth 2013; 27:551.72
336 TIGGES-LIMMER K, SCHONBRODT M, ROEFE D; et al. Suicide after ventricular assist device implantation. J Heart Lung Transplant 2010; 29:692-4
337 TOLLER W, ALGOTSSON L, GUARRACINO F, et al. Perioperative use of levosimendan: best practice in operative settings. J Cardiothorac Vasc Anesth 2013; 27:362-6
338 TOLLER WG, STRANZ C. Levosimandan, a new inotropic and vasodilator agent. Anesthesiology 2006; 104:556-69
339 TRACHTE AL, LOBATO EB, URDANETA F, et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg 2005; 79:194-7
340 TRONCY E, BLAISE G. Phenylephrine and inhaled nitric oxide. Anesthesiology 1998; 89:538-40
341 TROUGHTON RW, FRAMPTON CM, BRUNNER-LA ROCCA HP, et al Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. Eur Heart J 2014; 35:1559:67
342 TÜLLER C, NICOD LP. Hypertension pulmonaire chronique. Forum Méd Suisse 2008; 8:812-7
343 UNSWORTH B, CASULA RP, YADAV H, et al. Contrasting effect of different cardiothoracic operations on echocardiographic right ventricular long axis velocities, and implications for interpretation of postoperative values. Int J Cardiol 2013; 165:151-60
344 VACHIÉRY JL, ADIR Y, BARBERÀ JA, et al. Pulmonary hypertension due to left heart disease. J Am Coll Cardiol 2013; 62:D100-8
345 VANDENHEUVEL MA, BOUCHEZ S, WOUTERS P, DE HERT SG. A pathophysiological approach towards right ventricular function and failure. Eur J Anaesthesiol 2013; 30:386-94
346 VAN WEZEL HB, DEJONG SWM. Clinical use of glucose-insulin-potassium in cardiac surgery and acute myocardial infarction: an overview. Semin Cardiothorac Vasc Anesth 2003; 7:77-83
347 VASAN RS, LARSON MG, BENJAMIN EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33:1948-55
348 VELAZQUEZ EJ, BONOW RO. Revascularization in severe left ventricular dysfunction. J Am Coll Cardiol 2015; 65:615-24
349 VONK-NOORDEGRAAF A, HADDAD F, CHIN KM, et al. Right heart adaptation to pulmonary arterial hypertension. J Am Coll Cardiol 2013; 62:D22-33
350 VON LUEDER TG, KRUM H. New medical therapies for heart failure. Nat Rev Cardiol 2015; 12:730-40
351 VON SPIEGEL T, GIANNARIS S, SCHORN B, et al. Effects of induction of anaesthesia with sufentanil and positive-pressure ventilation on the intra- to extrathoracic voilume distribution. Eur J Anaesthesiol 2002; 19:428-35
352 WANG GY, McCLOSKEY DT, TURCATO S, et al. Contrasting inotropic responses to adrenergic receptor stimulation in left versus right ventricular myocardium. Am J Physiol Heart Circul Physiol 2006; 291:H2013-17
353 WAURICK K, RIESS H, VAN AKEN H, et al. Ruckenmarksnahe Regionalanästhesien und thromboembolieprophylaxe/antitrhombin medikation. 3. Überarbeitet Empfehlung der Deutschen Gesellschaft für Anästhesiologie und Intesivmedizin. Anästh Intensivmed 2014; 55:464-92
354 WEBER KT. Aldosterone and spironolactone in heart failure. N Engl J Med 1999; 341:753-5
355 WILKINS MR, GHOFRANI HA, WEISSMANN N, et al. Pathophysiology and treatment of high-altitude pulmonary vascular disease. Circulation 2015; 131:582-90
356 WILLIAMS JP. Effects of thoracic epidural anesthesia on the coagulation system. Bail Clin Anesthesiol 1999; 13:31-56
357 WINTERHALTER M, ANTONIOU T, LOUKANOV T. Management of adult patients with perioperative pulmonary hypertension: technical aspects and therapeutuc options. Cardiology 2010; 116:3-9
358 WYLER VON BALLMOOS M, TAKALA J, ROECK M, et al. Pulse-pressure variation and hemodynamic response in patients with elevated pulmonary artery pressures: a clinical study. Critical Care 2010; 14:R111
359 YANCY CW, JESSUP M, BOZKURT B, et al. 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology Foundation / American Heart Association on Practice Guidelines. Circulation 2013; 128:e240-e327
360 YANCY CW, SALTZBERG MT, BERKOWITZ RL, et al. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (FUSION trial). Am J Cardiol 2004; 94:595-601
361 YUSUF S, PFEFFER MA, SWEDBERG K, et al. Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362:777-81
362 ZARBOCK A, VAN AKEN H, SCHMIDT C. Management of right ventricular dysfunction in the perioperative setting. Curr Opin Anaesthesiol 2014; 27:388-93
363 ZILE MR, BRUTSAERT DL. New concept in diastolic dysfunction and diastolic heart failure: Part I. Diagnosis, prognosis, and measurement of diastolic function. Circulation 2002; 105:1387-93
364 ZILE MR, BRUTSAERT DL. New concept in diastolic dysfunction and diastolic heart failure: Part II. Causal mechanisms and treatment. Circulation 2002; 105:1503-8